Colorectal cancer screening issues: A role for CT colonography?

Abdominal Imaging

Volumn 27, Issue 3, 2002, Pages 235-243

  McMahon, P M ^a   Gazelle, G S ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Decis Anal/Technol Assess Grp   (United States)

Author keywords

Colorectal neoplasms; Computed tomographic colonography; Screening

Indexed keywords

BARIUM ENEMA; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; HUMAN; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SKILL; SURVIVAL RATE; ADENOMATOUS POLYP; ADULT; COLON; COLORECTAL TUMOR; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECTUM;

ADENOMATOUS POLYPS; ADULT; COLON; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTUM;

EID: 0036557971     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer statistics review, 1973-1996. NIH Publication No. 99-2789. Bethesda, MD: National Cancer Institute, 1999
2. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-662
3. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-1981
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-1477
5. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-1471
6. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-437
7. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995;87:417-426
8. Brown ML, Riley GF, Potosky AL, et al. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999;37:1249-1259
9. Mandel J, Church T, Bond J, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-1607
10. Centers for Disease Control. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR 2001;50:162-166
11. American Cancer Society. Cancer facts and figures, 2001. Last accessed June 25, 2001. Available from: http://www3.cancer.org/cancerinfo/
12. Burt RW, Bishop DT, Cannon L, et al. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540-1544
13. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer: A population-based study. N Engl J Med 1990;323:1228-1233
14. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and risk of colorectal cancer. N Engl J Med 1994;331:1669-1674
15. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-87
16. Thun MJ, Calle E, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 1992:84:1491-1500
17. Willett WC, Stampfer MJ, Colditz GA, et al. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990;323:1664-1672
18. Giovannucci E, Rimm E, Ascherio A, et al. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-273
19. Chao A, Thun M, Jacobs E, et al. Cigarette smoking and colorectal cancer mortality in the Cancer Prevention Study II. J Natl Cancer Inst 2000;92:1888-1892
20. Almendingen K, Hofstad B, Trygg K, et al. Smoking and colorectal adenomas: a case-control study. Eur J Cancer Prev 2000;9:193-203
21. Inoue H, Kiyohara C, Shinomiya S, et al. Glutathione S-transferase polymorphisms and risk of colorectal adenomas. Cancer Lett 2001;163:201-206
22. Terry P, Ekbom A, Lichtenstein P, et al. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001;91:585-587
23. Thun MJ. Aspirin and gastrointestinal cancer. Adv Exp Med Biol 1997;400A:395-402
24. Smalley W, Ray WA, Daugherty J, et al. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999;159:161-166
25. Taketo M. Cyclooxygenase-2 inhibitors in tumorigenesis (part II) [review]. J Natl Cancer Inst 1998;90:1609-1620
26. He T-C, Chan T, Vogelstein B, et al. PPARd is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999;99:335-345
27. Fuchs C, Giovannucci E, Colditz G, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-176
28. Michels K, Giovannucci E, Joshipura K, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000;92:1740-1752
29. Terry P, Giovannucci E, Michels K, et al. Fruit, vegetables, dietary fiber and the risk of colorectal cancer. J Natl Cancer Inst 2001;93:525-533
30. Baron J, Beach M, Mandel J, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107
31. Holt PR, Atillasoy EO, Gilman H, et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 1998;280:1074-1079
32. Jänne P, Mayer R. Chemoprevention of colorectal cancer [review]. N Engl J Med 2000;342:1960-1968
33. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-2270
34. Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984;35:425-431
35. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532
36. Fearon ER, Vogelstein B. A genetic model for colorectal turmorigenesis. Cell 1990;61:759-767
37. Takaku K, Oshima M, Miyoshi H, et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4(Smad4) and Apc genes. Cell 1998;92:645-656
38. Stevenson GW. Colorectal cancer imaging: a challenge for radiologists. Radiology 2000;214:615-621
39. Burt R. Colon cancer screening [review]. Gastroenterology 2000;119:837-853
40. Ivanovich HL, Read TE, Ciske DJ, et al. A practical approach to familial and hereditary colorectal cancer. Am J Med 1999;107:68-77
41. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-665
42. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-669
43. Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;66:601-613
44. Groden J, Thliveris A, Samowitz W, et al. Indentification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600
45. Rustgi A. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994;331:1694-1702
46. Giardiello FM, Petersen GM, Piantadosi S, et al. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997;40:521-525
47. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170
48. Aaltonen LA, Peltomäki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816
49. Selby JV, Friedman GD, Quesenberry CPJ, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-657
50. Cuzick J. Screening for cancer: future potential. Eur J Cancer 1999;35:685-692
51. Wolber R, Owen D. Flat adenomas of the colon. Hum Pathol 1991;22:70-74
52. Rembacken B, Cairns A, Dixon M, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000;355:1211-1214
53. Devesa S, Chow W. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993;71:3819-3826
54. Hahn DL. Sex and race are risk factors for colorectal cancer within reach of the sigmoidoscopy. J Fam Pract 1990;30:409-416
55. Offerhaus GJA, Giardiello FM, Tersmette KF, et al. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer 1991;49:641-644
56. Nelson RL, Dollear T, Freels S, et al. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997;80:193-197
57. Ozick LA, Jacob L, Donelson SS, et al. Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol 1995;90:758-760
58. Demers RY, Severson RK, Schottenfeld D, et al. Incidence of colorectal adenocarcinoma by anatomic subsite. Cancer 1997;79:441-447
59. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993;105:130-141
60. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 1995;87:1686-1693
61. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999;86:158-169
62. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-1371
63. Macrae FA, St. John JB. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-898
64. Ahlquist DA. Fecal occult blood testing for colorectal cancer. Gastroenterol Clin North Am 1997;26:41-55
65. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and Hemoquant tests. JAMA 1993;269:1262-1267
66. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult [entire issue]. Cochran Rev 1999;4
67. Castiglione G, Zappa M, Grazzini G, et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 1996;74:141-144
68. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-1668
69. Petrelli N, Michalek A, Freedman A, et al. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol 1994;3:27-36
70. Allison J, Tekawa I, Ransom L, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-159
71. Gyrd-Hansen D, Sogaard J, Kronberg O. Analysis of screening data: colorectal cancer. Int J Epidemiol 1997;26:1172-1179
72. Gillespie PE, Chambers TJ, Chan KW, et al. Colonic adenomas - a colonoscopy survey. Gut 1979;20:240-245
73. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:1775-1780
74. Gelfand DW, Ott DJ. The economic implications of radiologic screening for colonic cancer. Am J Radiol 1991;156:939-943
75. Gelfand DW. Screening for colon cancer: economics and related considerations. Semin Roentgenol 1996;31:170-176
76. Imperiale T, Wagner D, Lin C, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-174
77. Lieberman D, Weiss D, Bond J, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-168
78. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-1575
79. Timms B. U.K. researchers evaluate colorectal cancer screening [news]. Eur J Cancer 1999;35:684
80. Prorok P, Andriole G, Bresalier R, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials 2000;21:273S-309S
81. Bloomfield JA. Reliability of barium enema in detecting colonic neoplasia. Med J Austral 1981;1:631-633
82. Jaramillo E, Slezak P. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding. Gastrointest Radiol 1992;17:81-83
83. Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994;8:445-447
84. Steine S, Stordahl A, Lunde OC, et al. Double contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract 1993;10:288-291
85. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23
86. Rex DK, Lehman GA, Lappas JC, et al. Sensitivity of double-contrast barium study for left-colon polyps. Radiology 1986;158:69-72
87. Ott DJ, Scharling ES, Chen YM, et al. Positive predictive value and posttest probability of diagnosis of colonic polyp on single- and double-contrast barium enema. Am J Radiol 1989;153:735-739
88. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK consultant radiologists 1992-1994. Clin Radiol 1992;52:142-148
89. American College of Radiology. CRC screening background report. Reston, VA: American College of Radiology, 1998
90. Rex DK, Lehman GA, Hawes RH, et al. Screening colonoscopy in symptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991;100:64-67
91. Godreau CJ. Office-based colonoscopy in a family practice. Fam Pract Res J 1992;12:313-320
92. Jarvinen H, Aarnio M, Mustonen J, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834
93. Fenlon HM, Nunes DP, Schroy PC, et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999;341:1496-503
94. Hara AK, Johnson CD, Reed HE, et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 1997;205:59-65
95. Winawer S, Stewart E, Zauber A, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000;342:1766-1772
96. Laufer I, Smith NCW, Mullens E. The radiological demonstration of colorectal polyps undetected by endoscopy. Gastroenterology 1976;70:167-170
97. Miller RE, Lehman G. Polypoid colonic lesions undetected by endoscopy. Radiology 1978;129:295-297
98. Glick SN, Teplick SK, Balfe DM, et al. Large colonic neoplasms missed by endoscopy. Am J Radiol 1989;152:513-517
99. Rex DK, Cutler CS, Lemmel GT. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-28
100. Gelfand DW, Chen MYM, Ott DJ. Benign colorectal neoplasms undetected by colonoscopy. Gastrointest Radiol 1992;17:344-346
101. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 1991;37:125-127
102. Jentschura D, Raute M, Winter J, et al. Complications in endoscopy of the lower gastrointestinal tract: therapy and prognosis. Surg Endosc 1994;8:672-676
103. Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol 1992;15:347-351
104. Woolf S. The best screening test for colorectal cancer - a personal choice [editorial]. N Engl J Med 2000;343:1641-1643
105. O'Brien K, O'Connell R, O'Connell M. Screening for colorectal cancer [correspondence]. N Engl J Med 2000;343:1651-1654
106. Habr-Gama A, Waye JD. Complications and hazards of gastrointestinal endoscopy. World J Surg 1989;13:193-201
107. Kaczmarek RG, Moore RM, J M, et al. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med 1992;92:257-261
108. Johnson C, Dachman A. CT colonography: the next colon screening examination? Radiology 2000;216:331-341
109. Johnson CD, Hara AK, Reed JE. Computed tomographic colonography (virtual colonoscopy): a new method for detecting colorectal neoplasms. Endoscopy 1997;29:454-461
110. McFarland EG, Brink JA. Helical CT colonography (virtual colonoscopy): the challenge that exists between advancing technology and generalizability. Am J Radiol 1999;173:549-559
111. Yee J, Akerkar G, Hung R, et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology 2001;219:685-692
112. Rex D, Vining D, Kopecky K. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointest Endosc 1999;50:309-313
113. Wagner JL. Cost-effectiveness of screening for common cancers. Cancer Metastasis Rev 1997;16:281-294
114. Bolin T. Cost benefit of early diagnosis of colorectal cancer. Scand J Gastroenterol 1996;31(suppl):142-146
115. Toribara N, Sleisenger M. Screening for colorectal cancer. N Engl J Med 1995;332:861-867
116. Barry MJ, Mulley AG, Richter JM. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology 1987;93:301-310
117. England WL, Halls JJ, Hunt VB. Strategies for screening for colorectal carcinoma. Med Decis Making 1989;9:3-13
118. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113:373-384
119. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-1790
120. Office of Technology Assessment. Cost-effectiveness of colorectal cancer screening in average-risk adults. OTA-BP-H-146. Washington, DC: Office of Technology Assessment. 1995
121. Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. Am J Radiol 1998;170:629-636
122. Gyrd-Hansen D. Fecal occult blood tests: a cost effectiveness analysis. Int J Technol Assess Health Care 1998;14:290-301
123. Whynes DK, Nielson AR, Walker AR, et al. Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ 1998;7:21-29
124. Norum J. Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy. Ann Oncol 1998;9:613-618
125. Sonnenberg A, Delco F, Bauerfeind P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer. Am J Gastroenterol 1999;94:2268-2274
126. Sonnenberg A, Delco F, Inadomi J. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133
127. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
128. McMahon P, Bosch J, Gleason S, et al. Cost-effectiveness of colorectal cancer screening. Radiology 2001;219:44-50
129. Helm J, Russo M, Biddle A, et al. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol 2000;95:3250-3258
130. Frazier A, Colditz G, Fuchs C, et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-1961
131. Loeve F, Brown M, Boer R, et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 2000;92:557-563
132. Torgerson D, Donaldson C. An economic view of high compliance as a screening objective. BMJ 1994;308:117-119
133. Johnson T. Dying of embarrassment. 20/20, ABC News, 1998
134. Cool L. The preventable cancer. Good Housekeeping 1998;October:129-192
135. Powell J. Katie's crusade. Good Housekeeping 1998;October:124-188
136. Gower T. The preventable deadly cancer. Health 2000;January/February:74-79
137. Roan S. Colorectal cancer is focus of long overdue attention; prevention efforts coalesce to raise awareness of a lethal disease that can be treated if detected early on. Los Angeles Times 2000; March 13:1-6
138. Fed Reg 1997;62:59078-59082
139. Centers for Disease Control. Screening for colorectal cancer - United States, 1997. MMWR 1999;48:116-121
140. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-1422
141. Sharma V, Corder F, Fancher J, et al. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol 2000;95:3629-3632
142. Steine S. Which hurts the most? A comparison of pain rating during double-contrast barium enema examination and colonoscopy. Radiology 1994;191:99-101
143. Williams C, Macrae F, Bartram C. A prospective study of diagnostic methods in adenoma follow-up. Endoscopy 1982;14:74-78
144. Akerkar GA, Hung RK, Yee J, et al. Virtual colonoscopy: real pain [abstract]. Gastroenterology 1999;116:G0186